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ABSTRACT 
In this era of globalization and standardization there is a dire need to arrive at a consensus in the 
approach to the treatment of the diseases in Ayurveda. It is an essential tool not only for proper 
understanding of the pathology, appropriate diagnosis, and treatment, but also for scientific 
documentation and generation evidence for global acceptance and appreciation among the scientific 
community.  
Classics clearly demarcate the effects of Sweda as an operative and as a pre-operative/post-operative 
(or both procedures). Considering the therapeutic importance of one such Swedana modality, study 
was attempted on standardization of the procedure of Dhanyamla dhara, a form of Parisheka sweda.  
Based on the references in the classics, the data collected through questionnaires and personal 
interviews a protocol was developed and it was clinically tested in the disease, Rheumatoid Arthritis. 
The study was carried out in the Department of Panchakarma, Government Ayurveda College, 
Tripunithura. Patients diagnosed of Rheumatoid Arthritis (As per American College of Rheumatology 
revised criteria 1987) under the age group of 16-60 years were selected according to the inclusion 
criteria and were admitted to the IP Unit. Assessment was done by using clinical parameters 
(objective and subjective) before treatment and after treatment. The results were statistically 
analyzed using the most appropriate statistical tests. Significant results were noted in all the clinical 
parameters such as joint pain, joint swelling, tenderness, general functional capacity signifying the 
effectiveness of Dhanyamla dhara in improving the clinical features and quality of patient’s life. 
KEYWORDS: Swedana, Dhanyamla dhara, Parisheka sweda, Rheumatoid Arthritis. 
INTRODUCTION
Ayurveda being a science with a very rich 
legacy, somewhere lacked to convince the masses. For 
global acceptance of Ayurveda and related 
Panchakarma therapies - thoroughly conducted 
researches, standardization of the different therapeutic 
techniques and hence setting therapeutic standards is 
needed, so that this unique therapeutic modality may 
be acknowledged worldwide. 
During the course of time, in Ayurveda various 
therapies have been developed and customized as per 
the requirement of the present era, which needs 
standardization, for acceptability by the whole 
scientific community, and should be practically 
assessable to the physician and patients without 
hampering the basic concepts of Ayurveda.  
One such very less explored theory is that of 
Swedana. Acharya Charaka has mentioned Swedana 
under Shad-upakramas [1], thus respecting Swedana as a 
principal method of treatment. Diseases of Vatavaha 
srotas as well as Asthivaha srotas can be effectively 
managed with Dhanyamla having properties of 
Vatanulomana, Shula prashamana, Nadi uttejaka, 
Vedana sthapana, Mastishka balakaraka and Sheeta 
prashamana[2]. Vata-rakta is a typical example of 
Avarana Vata. If we analyze the sign and symptoms of 
Rheumatoid arthritis and Vatarakta, we will be able to 
understand a very close similarity between the 
diseases. Swedana karma is indicated in Samaja and 
Kaphadika Vatavyadhis[3]. Dhanyamla is Vata-
kaphahara and Amahara, hence indicated in Vatasonita 
specifically in Uttana Vatarakta having symptoms like 
Daha, Raga, Kandu etc. as Drava sweda for Parisheka [4]. 
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Earlier works carried out 
1. Ranasinghe R.L.D.S. under the guidance of Prof 
Ediriweera E.R.H.S.S, Comparative evaluation of 
Dhanyamla Vasti and Kayasheka in the 
management of Amavata w.s.r. to Rheumatoid 
Arthritis. Department of Nidana Chikitsa, Post 
graduate Unit, Institute of Indigenous Medicine, 
University of Colombo.  
2. Ollakkod S. under the guidance of Prasad KSR, 
Evaluation of comparative efficacy of Alambushadi 
yoga and Dhanyamla Kayasheka in Amavata 
(Rheumatoid Arthritis), 2004, Department of 
Kayachikitsa (PG), Post graduate studies and 
research centre, D.G.M. 
Objectives 
1) To standardize the procedure of Dhanyamla 
dhara. 
2) To assess the efficacy of Dhanyamla dhara in 
reducing signs & symptoms of Rheumatoid 
Arthritis 
3) To know whether the treatment improves the 
functional capability of Rheumatoid Arthritis 
patients. 
MATERIALS AND METHODS 
Study population 
The population comprises of 30 patients 
diagnosed of Rheumatoid Arthritis (RA) as per the 
inclusion criteria and they were randomly divided into 
two groups comprising of 15 patients in each group by 
lottery method. Dhanyamla was administered in the 
form of Dhara for 7 days. 
Settings of the study 
Population: Diagnosed cases of Rheumatoid 
Arthritis coming under the inclusion criteria. 
Sample: The patients (samples) were selected from the 
OP units of the Dept. of Panchakarma, Govt. Ayurveda 
College Hospital, Tripunithura. Patients were randomly 
selected for the study.  
Sample frame 
a. Study design: Randomized interventional 
comparative clinical trial 
b. Sample size: 30 (2 groups – 15 patients in each 
group) 
c. Study duration: 18 months 
d. Selection of patients: As per inclusion and 
exclusion criteria 
e. Study setting: Govt. Ayurveda College Hospital, 
Tripunithura, Kerala. 
Criteria for Diagnosis 
Criteria for diagnosis were as per American 
College of Rheumatology (ACR)[5], 1987 revised criteria 
for the classification of Rheumatoid arthritis. Routine 
haematological, urine, biochemical investigations were 
carried out to exclude any other pathological condition. 
Inclusion criteria 
a. Patients diagnosed to have Rheumatoid 
Arthritis (based on revised ARA criteria for the 
diagnosis of RA).  
b. Patients between 16 – 60 years of age. 
c. Patients of both sexes. 
d. Patient willing to give written informed 
consent. 
 Exclusion criteria 
a. Swedana anarhas[6] 
b. Patients diagnosed with bone disorders like 
malignancy, Gout, and Bone marrow disorder. 
c. Patients below 16 and above 60 years of the age. 
d. Patients with complications like deformity, 
complete loss of functions, patients with cardiac 
disorders, severe hepatic disorders, endocrinal 
disorders, pregnant and lactating females. 
e. Any other condition that may jeopardize the study. 
Drug preparation 
Dhanyamla was prepared in the pharmacy of 
Govt. Ayurveda College Hospital, Tripunithura as per 
“Sahasrayogam” [7] (Figure no. 1) wherein it is mentioned 
that it can be used in all 80 types of Vatarogas. 
Drug intervention 
  Questionnaire (Purvakarma, Pradhanakarma, 
Paschatkarma along with details regarding Dhanyamla 
dhara like quantity, time, amount, pH, positions etc.) 
was prepared after detailed study of the Ayurvedic 
literature and other authentic available resources 
about Dhanyamla dhara.  
  Hundred eminent scholars and successful 
practitioners of Ayurveda, inside and outside Kerala 
were chosen. The prepared questionnaires were 
distributed through e-mails.  
a) Selection of a protocol from the collected data  
  Based on the references in the classics, the 
data collected through questionnaires and personal 
interviews a protocol was developed and it was 
clinically tested in Rheumatoid Arthritis. 
Materials Required  
Dhanyamla (3-4 litres/day), Vessels (Two), Soft 
towels (Three), Oil for talam[8] (10 ml), Rasnadi churna[10] 
(5 gm), Gauze (One), Cotton ear plugs (Two), Masseurs 
(Two), Attendant (One), Thin cloth (1-approx.2m x 1m), 
Jambeera/lemon (half piece).  
All these standards were same for both the groups 
except that thin cloth was required for covering the 
patient’s body in Group B only.  
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Table no.-1 Showing allocation of patients in two groups 
Group A 
Dhanyamla dhara was done according to practices followed, without covering patient’s body and 
with single stream of Dhara. (with the help of Kindi) 
Group B 
Dhanyamla dhara done after data collection and making standard protocol. All other parameters 
were kept same as for group A except that in this group patient’s whole body, below the neck area 
was covered by a thin cloth and multiple stream/Sahasra dhara was done. 
Procedure of Dhanyamla dhara administration  
a. Purvakarma 
b. Pradhana Karma 
c. Paschat Karma 
a. Purvakarma (Pre-operative procedures)  
 Patient was made to sit on the Droni, Talam 
(specific for each disease) of Rasnadi choornam and 
Jambeera swarasa, was kept on the bregma part of the 
head. Gauze was tied around the head above the eye 
brows. Ears were plugged with cotton. This protocol 
was followed for Group-A patients but for Group-B, 
patient’s whole body below the neck was covered with 
a thin cloth.  
b. Pradhana karma (Main procedure) 
The temperature of Dhanyamla was kept 
around 40oC - 44oC avoiding any discomfort to the 
patient at that temperature. Warm Dhanyamla was 
poured with kernels/mugs (Kindi-vernacular 
Malayalam) in group A patients and by gardening 
pitcher in group B patients, by two attendants standing 
on either side of the Droni. Dhara was done at a 
medium speed and from a height of 9-12 cm.  
Daily fresh Dhanyamla was taken. The entire 
procedure was done in seven positions. Dhara was 
done for 6-7 minutes in each position coming to a total 
of approximately 42-49 minutes every day. The time 
duration can be increased or decreased according to 
the condition and need of the patient and the disease.  
c. Paschat karma (Post operative procedure) 
 After Dhara, the body and head was cleaned 
carefully so that no moisture is retained. Ear plugs, 
gauze was removed and after wiping well with a dry 
cloth, Rasnadi choornam was applied to the head. 
Ghandharvahastadi kashaya [9] (75 ml) was given to the 
patient as Pathy kashaya [10], a Malayalam vernacular 
term denoting the post–operative internal medication. 
The aim of this Kashaya is to drain the daily 
accumulated by products of the body metabolism, 
owing to augmented permeability by Swedana. It helps 
to maintain the normal order of bodily functions. Rest 
was advised for about 45 minutes followed by body 
wash with pleasantly warm water. Then food intake 
was allowed with the prescribed restrictions. Same 
procedure of Dhara with Dhanyamla was done for 7 
days.  
ASSESSMENT CRITERIA 
 The assessment was made using clinical 
parameters. The findings and results were recorded 
before and after Dhanyamla dhara. 
1. Pain 
Table 2 (A): Quantitative pain assessment: How often is it painful to 
  
 
Without 
difficulty 
Some 
difficulty 
Much 
difficulty 
Unable 
to do 
Before 
Treatment 
After 
Treatment 
a) Dress yourself? 0 1 2 3   
b) Get in and out of bed? 0 1 2 3   
c) Lift a cup or glass to your lips? 0 1 2 3   
d) Walk out doors on flat ground? 0 1 2 3   
e) Wash and dry your entire body? 0 1 2 3   
f) Bend down to pick up clothing 
from the floor? 
0 1 2 3   
g) Turn faucets on or off? 0 1 2 3   
h) Get in and out of a car / bus etc.? 0 1 2 3   
Total Score       
0-4- Normal; 5-12-  Adequate;  13-20- Impaired; 21-  24- Disabled 
(B) Visual analogue scale (VAS) 
A scale 10 cm was drawn on a paper and the 
patient was instructed mark against the reading 
relating to his or her pain severity before and after 
treatment, which was considered to be the initial pain 
scale readings. The procedure was done before and 
after the treatment. 
0 - Nil 
1-3 - Mild 
4-6 - Moderate  
7 and above - Severe 
 
 
 
Arun Kumar Bhadula et al. A Clinical Study to Standardize the Procedure of Dhanyamla Dhara and to Assess its  
Efficacy in Rheumatoid Arthritis 
 Available online at : http://ijapr.in  22 
2. Swelling  
Score  Symptom 
0 - No swelling 
1 - slightly obvious  
2 - covers well the bony prominence/ 
Moderate 
3  much elevated so that joints seems 
grossly deformed/ severe 
3. Stiffness 
Score  Symptom 
0 - No stiffness 
1 - Stiffness lasting for 30 minutes 
2 - Stiffness lasting up to 60 minutes 
3  Stiffness lasting for more than 1 hour 
4. Warmth  
Score  Symptom 
0 - Normal 
1 - Below 
2 - Raised 
5. Tenderness  
Score  Symptom 
0 - No tenderness 
1 - Subjective experience of tenderness 
2 - Wincing of face on pressure  
3 - Wincing of face with withdrawal of 
affected parts on pressure 
4 - Resistance to touch 
6. Range of movement: The range of movements 
was assessed with the help of Goniometer. Ranges 
of movement before and just after treatments were 
recorded for both the groups. 
 The Range of movement was taken as below: 
Ankle  Dorsi Flexion, Plantar Flexion 
Knee - Flexion 
Elbow - Flexion, Dorsi Flexion 
Wrist - Plantar Flexion, Abduction 
Shoulder - Flexion, Extension 
Here assessment is based on the degree of movements. 
7. General Functional Capacity  
Score  Symptom 
0 - Complete ability to carry or all 
routine duties without handicap 
1 - Frequent normal activity despite slight 
difficulty in joint movements 
2 - Few activities are persisting but 
patient can take care of him/herself 
3  Few activities are persisting, patient 
requires an attendant to take care of 
him/herself 
4  Patient is totally bed ridden 
8. Walking time: Patients were asked to walk a 
distance of 40 feet and the time taken was 
recorded before and after the treatment. 
Score  Walking time (in secs) 
0 - 30-40 
1 - 41 – 50 
2 - 51 – 60 
3  More than 60 
9. Grip strength: To find the functional capacity of 
affected upper limb, the patient’s ability to 
compress an inflated ordinary sphygmomanometer 
cuff under standard condition was carried out and 
the findings were recorded before and after 
treatment. 
Grip strength 
score 
 Pressure in 
sphygmomanometer  
0 - 200 mm Hg or more 
1 - 198 – 200 mm Hg 
2 - 118 – 70 mm Hg 
3  Under 70 mm Hg 
Laboratory Parameters used for assessment 
1. RA factor  
2. Estimation of Acute phase reactants 
a) Erythrocyte Sedimentation Rate (ESR) 
b) C - reactive protein (CRP). 
   Score   
0  Negative (less than 6 IU) 
1   Positive (more than 6 IU) 
RESULTS AND DISCUSSION  
Criteria for the Assessment of the total effect of the therapy  
The subjective and objective criteria were assessed before and after treatment. The data obtained in clinical study 
was subjected to following two statistical tests (for parametric/non-parametric data) and was analyzed 
accordingly; 
1. The Wilcoxon signed rank test  
2. Student paired‘t’ test 
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1. Pain 
Table 3: Showing effect of therapy as per (a) Quantitative pain assessment  
 
 
 
 
 
 
BT-Before treatment At- After treatment 
The statistical analysis of the quantitative pain assessment showed extremely significant results in both the groups 
after treatment. There was gradual reduction of pain in patients of both the groups. Gradual improvement in joint 
movements was seen due to reduced pain. The results were more significant in group B (Z-value – 3.192), as 
compared to group A (Z-value - 3.351). So Dhanyamla dhara is very effective in reducing the pain. 
Table 4: Showing effect of therapy on (b) Visual analogue scale for pain
 Group A Group B 
 Scores BT AT BT AT 
0  0 0 0 0 
1 – 3 0 11 0 12 
4 – 6 2 4 4 3 
7 & above 13 0 11 0 
Total 15  15  15  15  
 Mean  
Z value 
 
p value BT AT 
Group A 7.466 3.266 -3.443 .0005 
Group B 7.2 3.066 -3.496 .0004 
Analysis of Visual Analog Scale (VAS) to assess pain showed a highly significant reduction in pain after treatment. Z-
values for both the groups showed that it was more significant for group B than group A.  
2. Swelling 
Table 5: Showing effect of therapy on Swelling in joints 
 Group A Group B 
 Scores BT AT BT AT 
0  0 0 1 3 
1  0 9 4 7 
2 8 6 8 5 
3 7 0 2 0 
Total 15  15  15  15  
 Mean Z value p value 
BT AT 
Group A 2.466 1.6 -3.606 .003 
Group B 1.733 1.133 -2.714 .006 
The mean changes, hence the reduction of joint swelling is statistically significant in both the groups after 
treatment. Because of the reduction in swelling, the range of movement of the major joints was increased. The 
results were more significant in group A at p-value .003 than in group B at p value .006. But overall Dhanyamla 
dhara is found to be very effective in reducing the swelling. 
 
 
 
 
 Group A Group B 
 Scores BT AT BT AT 
0 - 4 2 2 2 3 
5 - 12 4 4 3 6 
13 -20 6 9 8 6 
21 - 24 3 0 2 0 
Total 15  15  15  15  
 Mean Z-
value 
p-
value BT AT 
Group A 14.533 12.2 -3.192 .0008 
Group B 14 11.067 -3.351 .0002 
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3. Stiffness 
Table 6: Showing effect of therapy on Stiffness 
 Group A Group B 
 Scores BT AT BT AT 
0  0 2 0 1 
1  3 5 3 5 
2 6 7 6 9 
3 6 1 6 0 
Total 15  15  15  15  
  Mean Z value p value 
BT AT 
Group A 2.2 1.467 -2.810 .005 
Group B 2.2 1.533 -2.887 .004 
In both categories of patients, the analysis showed significant results after treatment, due to the reduction of 
stiffness of muscles and joints, the subjects from both the groups were able to walk without or with minimal 
support. For most of the patients, duration of morning stiffness was reduced otherwise. So the therapy was effective 
in reducing the stiffness. 
4. Warmth 
Table 7: Showing effect of therapy on Warmth 
 Group A Group B 
 Scores BT AT BT AT 
0  5 11 4 12 
1  2 2 3 2 
2 8 2 8 1 
Total 15  15  15  15  
  Mean  
Z value 
 
p value BT AT 
Group A 1.2 .4 -2.449 .014 
Group B 1.2667 .2667 -2.714 .006 
The mean changes, before and after treatment were significant statistically in group A and highly significant in 
group B. This might be because of the anti-inflammatory effect of Dhanyamla 
5. Tenderness 
Table 8: Showing effect of therapy on Tenderness – Group A 
  Mean Z value p value 
BT AT 
Ankle jt. Rt. Group A 3 1.33 -3.494 .0004 
Group B 3.067 1.133 -3.771 .0001 
Ankle jt. Left Group A 3 1.2 -3.535 .0004 
Group B 3.066 1.133 -3.771 .0001 
Knee jt. Right Group A 3.066 1.266 -3.626 .0002 
Group B 3.133 1.4 -3.557 .0003 
Knee jt. Left Group A 3.067 1.333 -3.578 .0003 
Group B 3.133 1.4 -3.557 .0003 
Elbow jt. Right Group A 3.066 1.333 -3.557 .0003 
Group B 3.2 1.533 -3.494 .0004 
Elbow jt. Left Group A 3 1.2 -3.354 .0007 
Group B 3.2 1.466 -3.578 .0003 
Wrist jt. Right Group A 2.667 1.133 -3.416 .0006 
Group B 2.733 1.133 -3.52 .0004 
Wrist jt. Right Group A 2.666 1.2 -3.314 .0009 
Group B 2.733 1.2 -3.416 .0006 
In both categories of patients, the analysis showed extremely significant results after treatment at p < .001 level. 
Due to the reduction of tenderness of joints, subjects from both the groups were able do their work themselves. 
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6. General Functional Capacity 
Table 9: Showing the effect of therapy on General functional capacity  
 Group A Group B 
 Scores BT AT BT AT 
0  0 0 0 2 
1  2 4 3 3 
2 7 6 4 3 
3 5 4 5 4 
4 1 1 3 3 
Total 15  15  15  15  
  
Mean 
Z value p value 
BT AT 
Group A 2.333 2.133 -1.732 .0832 
Group B 2.6 2.2 -2.449 .0143 
The mean changes, before and after treatment is insignificant statistically in group A, whereas found to be 
significant in group B. The patients of Group B were able to take care of themselves and do work with slight joint 
pains and deformities. 
7. Walking Time (in seconds) 
Table 10: Showing effect of therapy on walking time 
 Group A Group B 
 Scores BT AT BT AT 
0  1 2 3 5 
1  5 11 6 9 
2 6 2 5 1 
3 3 0 1 0 
Total 15  15  15  15  
  Mean  
Z value 
 
p value BT AT 
Group A 1.733 1 -2.81 .0049 
Group B 1.2667 .733 -2.82 .0046 
The mean score of walking time in both the Groups reduced after treatment. The mean changes, before and after 
treatment were significant statistically in group A and B, but Z-value shows it to be more significant in group B than 
A. There were significant results in the walking time in patients of both the groups due to reduction of inflammatory 
changes in the joints. This indicates that there is increase in functional capability of subjects due to treatment. 
8. Grip Strength 
Table 11: Showing effect of therapy on grip strength 
 Group A Group B 
 Scores BT AT BT AT 
0  1 3 2 6 
1  6 10 4 7 
2 5 2 6 2 
3 3 0 3 0 
 Mean  
Z value 
 
p value BT AT 
Group A 1.733 .933 -2.972 .0029 
Group B 1.66 .733 -2.889 .0038 
Grip power was found to be statistically highly significant after treatment in both the groups with p-value .003. This 
improvement shows that the power of the joint was increased due to treatment and showed good results in the 
minor joints that were affected. 
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9. Rheumatoid Arthritis (RA) Factor 
Table 12: Showing effect of therapy on RA factor  
 Mean  
Z value 
 
p value Before Treatment After Treatment 
Group A 1.2 1.2 0 1 
Group B 1.066 1.333 1 .317 
Table 13: Showing effect of therapy on RA factor (Quantitatively) 
 
 
 
N 
Mean S.D. 
BT 
S.D. 
AT 
t value p 
value BT AT 
Group A 15 158.21 140.11 52.821 52.74 3.114 .008 
Group B 15 188.79 119.55 69.372 55.647 6.581 .000 
The mean changes, before and after treatment were insignificant statistically in both the groups.  
At the same time when paired sample ‘t’ was applied for the parametric data of RA factor then the results were 
found to be statistically highly significant in both the groups after treatment. This analysis shows that there was 
remarkable decrease in the values of RA factor after therapy, hence improvement in the immunological changes 
taking place in the body. 
10. Erythrocyte Sedimentation Rate (ESR) 
Table 14: Showing effect of therapy on ESR  
  
N 
Mean  
S.D. BT 
 
S.D. AT 
 
t value 
 
p value BT AT 
Group A 15 67.06 25.867 24.010 7.846 8.445 .0001 
Group B 15 59.6 28.800 30.757 20.685 4.413 .0010 
There were significant results statistically in the reduction of ESR after treatment in both the groups. The reduction 
in ESR represents reduced inflammation of joint and joint capsule which improved the quality of life of patients in 
both the groups. This reduction is highly impressive due to the relief of disease process. 
11. C – Reactive Protein  
Table 15: Showing effect of therapy on C-reactive protein 
 Group A Group B 
Scores BT AT BT AT 
0 2 13 2 13 
1 13 2 13 2 
Total 15 15 15 15 
 Mean Z value p value 
BT AT 
Group A .8667 .1333 3.317 .0009 
Group B .8667 .1333 3.317 .0009 
The mean score of CRP values in both the 
groups before treatment and after treatment were 
extremely significant statistically at p<.001. This 
indicates that Dhanyamla remarkably reduced the 
inflammatory changes and hence decrease in signs and 
symptoms of inflammation in both the groups. 
DISCUSSION 
Vatarakta is considered as Avaranjanya vata 
vyadhi. Acharya Charaka [11] and Vagbhata [12] have 
advised therapies that are Anabhisyandi, Snigdha and 
which help in the cleansing of the channels of 
circulation (Srotoshodhana). If ailment is caused by the 
aggravated Vayu occluded by Pitta then, the patient 
should be specially given heating and cooling therapies 
alternatively [13].  
“Ushnaveeryo himasparshi”[14] is property of 
Amla rasa which is also manifested in Dhanyamla as it 
is Sheeta (cold) at Sparsha (perception) which 
alleviates Rakta by its nature and Ushna in Guna and 
Veerya (potency) which alleviates Vata, hence is ideal 
for external administration in Rakta-avarita vata. 
Hence Dhanyamla by virtue of its Amla rasa and Ushna 
veerya not only does Srotoshodhana and alleviation of 
Vata and Rakta but also does Anulomana of Vata. Hence 
it has got all the desirable properties to be used in 
Rakta-avarita vata. As per the assessment criteria 
Dhanyamla dhara was found to be statistically and 
clinically effective in all the parameters (viz. pain, 
stiffness, warmth, Range of motion etc.) taken for 
assessment.  
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CONCLUSION 
The standardized procedure adopted in Group 
B was found more effective and beneficial, without any 
complications, in comparison to the method adopted 
for Group A. Minor complications (as observed in 
Group A) like chills and rigors, arising during 
Dhanyamla dhara may happen due to uneven 
maintenance of temperature of Dhanyamla or 
prolonged time gap between the changing up of fresh 
warm Dhanyamla or if body is exposed to cold breeze, 
which can be simply avoided by doing Dhara after 
covering the patient’s body with a thin cloth, as it will 
help in maintaining the body temperature throughout 
the procedure.  
Treatment responses were highly significant in 
most of the parameters assessed which clearly implies 
that Dhanyamla dhara remarkably reduces the signs & 
symptoms of RA, especially Acute or Acute-on-chronic 
cases and can relieve intense pain, reduce swelling and 
improves functional capacity within 7 days.  
So it can be concluded that Dhanyamla dhara 
can be incorporated as a safe & effective part of 
treatment protocol for the management of Vatarakta 
having acute signs and symptoms as mentioned by the 
Acharyas. 
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